Ricovr Healthcare reported raising $2 Million in an initial SEC Form D filing, from an offering of $4 Million

Company

Location

About

RICOVR Healthcare, based in Princeton, NJ, is the creator of the XALIVA® rapid diagnostics platform that provides high-quality, rapid diagnostic results using only a small amount of saliva. The company’s product pipeline includes rapid point-of-care tests for THC, drugs-of-abuse, reproductive health, and infectious diseases. RICOVR is proud to be guided by a distinguished advisory board and management team of scientists and engineers committed to positively impacting society. In addition, the company has strong partnerships with leading research institutions and medical device manufacturing companies around the globe. RICOVR’s testing platform leverages the first truly portable nanoparticle detection technology, allowing for fast, non-invasive point-of-care diagnostics. With the collaboration of industry experts, the company’s platform is versatile and already expanding into new point-of-care diagnostics, including drugs-of-abuse, reproductive health, and infectious disease testing. RICOVR is driven by the belief that a more accurate and cost-effective solution should be available for employers, law enforcement, healthcare systems, and others relying on fast and reliable diagnostic testing. RICOVR team includes experts across medical device design and manufacturing, leadership, sales, medicine, technology, and scientific research to improve human health outcomes by transforming point-of-care diagnostics.